Examples of Food and Drug Law in a sentence
Bodily injury" or "property damage" arising out of the use, sale, manufacture, delivery, transfer or possession by any person of a Controlled Substance as defined by the Federal Food and Drug Law at 21 U.S.C.A. Sections 811 and 812.
Hostile fire means one which becomes uncontrollable or breaks out from where it was intended to be.d. Loss arising out of the use, sale, manufacture, delivery, transfer or possession of a controlled substance(s) as defined by the Federal Food and Drug Law at 21 U.S.C.A. sections 811 and 812.
Gamerman, “Regulation of Biologics Manufacturing: Questioning the Premise,” Food and Drug Law Journal, vol.
Arising out of the use, sale, manufacture, delivery, transfer or possession by any person of a Controlled Substance(s) as defined by the Federal Food and Drug Law at 21 U.S.C.A. Sections 811 and 812.
Bodily injury" or "property damage" arising out of the use, sale, manufacture, delivery, trans- fer or possession by any person of a Con- trolled Substance as defined by the Federal Food and Drug Law at 21 U.S.C.A. Sections 811 and 812.
Dudzinski, “Reflections on Historical, Scientific, and Legal Issues Relevant to Designing Approval Pathways for Generic Versions of Recombinant Protein-Based Therapeutics and Monoclonal Antibodies,” Food and Drug Law Journal, vol.
Keynote Address at the 2018 Food and Drug Law Institute Annual Conference, Washington, DC (May 3, 2018) (Emphasis added).
Any person or company found to be in violation of any provision of the Food and Drug Law 1992, PNDCL 305B will be subject to a court penalty unit (the fine is not fixed) to be determined by the law court or imprisoned for not more two years or both.
In situations where Congress has implausibly extended its enumerated powers, this would call into play both Amendments: the Ninth, as establishing the proper rule of construction, and the Tenth, as prohibiting the exercise of any power not fairly attributable to an enumerated power.
Dudzinski, “Reflections on Historical, Scientific, and Legal Issues Relevant to Designing Approval Pathways for Generic Versions of Recombinant Protein-Based Therapeutics and Monoclonal Antibodies,” Food and Drug Law Journal, 2005, vol.